home / stock / dva / dva news


DVA News and Press, DaVita Inc. From 11/07/23

Stock Information

Company Name: DaVita Inc.
Stock Symbol: DVA
Market: NYSE
Website: davita.com

Menu

DVA DVA Quote DVA Short DVA News DVA Articles DVA Message Board
Get DVA Alerts

News, Short Squeeze, Breakout and More Instantly...

DVA - DaVita Non-GAAP EPS of $2.85 beats by $0.81, revenue of $3.12B beats by $100M

2023-11-07 16:11:20 ET More on DaVita DaVita: Simple And Compelling After Sell-Off Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial? DaVita: Continued Economic Hurdles, Market Expectations May Be Correct DaVita Q3 2023 Earnings Preview...

DVA - DaVita Inc. 3rd Quarter 2023 Results

DaVita Inc. 3rd Quarter 2023 Results PR Newswire DENVER , Nov. 7, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023 . "We delivered another strong quarter," said Javier Rodrig...

DVA - Expected US Company Earnings on Tuesday, November 7th, 2023

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

DVA - Expected earnings - DaVita Inc.

DaVita Inc. (DVA) is expected to report $1.92 for Q3 2023

DVA - Rare Stock Picks In October 2023 - From 31 Discerning Analysts

2023-11-04 12:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. We highlight October investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling ideas hard to come...

DVA - DaVita Unveils New Research to Drive Health Equity and Improve Care Quality during Annual American Society of Nephrology Meeting

DaVita Unveils New Research to Drive Health Equity and Improve Care Quality during Annual American Society of Nephrology Meeting PR Newswire Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-spea...

DVA - DaVita: Simple And Compelling After Sell-Off

2023-10-26 09:46:18 ET Summary Concern over weight loss drug Semaglutide has caused an unjustified sell-off in DaVita shares. Dialysis is essential to life for people with late-stage chronic kidney disease, making DaVita non-cyclical and resilient in any macro. DaVita has a si...

DVA - DaVita stock price forecast: Ozempic sell-off is an overreaction

2023-10-25 08:13:57 ET DaVita (NYSE: DVA) stock price has come under intense pressure in the past few days. The stock made a big dive on October 9th and crashed to a multi-month low of $71.45. While it has bounced back slightly, it remains 30% below the highest level this year. Similarl...

DVA - 3 Stocks to Buy From the 'Buy the Dip' ETF

2023-10-23 08:00:37 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Are you the type of investor who likes to buy the dip? Are you there buying good companies when their stocks hit 52-week lows? I’m sure Warren Buffett’s been guilty of this severa...

DVA - DaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Care

DaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Care PR Newswire Kidney care provider harnesses the power of Google Cloud's leading-edge infrastructure, AI, and analytics tools to help improve care plans and st...

Previous 10 Next 10